Press release
Investigation announced for Investors who lost money with shares of Outset Medical, Inc. (NASDAQ: OM) over possible Violations of Securities Laws
An investigation for investors in Outset Medical, Inc. (NASDAQ: OM) shares over potential securities laws violations.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series of statements by Outset Medical, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Jose, CA based Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
Outset Medical, Inc. reported that its annual Total Revenue rose from $115.37 million in 2022 to $130.37 million in 2023, and that its Net Loss increased from $162.95 million in 2022 to $172.79 million in 2023.
On August 7, 2024, Outset Medical, Inc. reported its second-quarter financial results, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance. The company's revenue for Q2 2024 fell to $27.4 million, a significant drop from $36.0 million in the same period the previous year. Product revenue also diminished, reaching only $19.2 million. Additionally, new console placements did not meet expectations, further impacting overall performance. As a result, Outset Medical, Inc. revised its full-year 2024 revenue guidance to $110 million, a substantial reduction from the earlier projected range of $145 to $153 million.
Shares of Outset Medical, Inc. (NASDAQ: OM) declined from $4.84 per share on July 16, 2024, to low as $.05750 per share on August 21, 2024.
Those who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors who lost money with shares of Outset Medical, Inc. (NASDAQ: OM) over possible Violations of Securities Laws here
News-ID: 3632012 • Views: …
More Releases from Shareholders Foundation, Inc.
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for long term investors in…
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc.
Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at…
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Outset
Caramanna, Friedberg LLP Represents Professionals from the outset of any Investi …
Image: https://www.globalnewslines.com/uploads/2025/07/1752223490.jpg
Disciplinary proceedings before a regulatory tribunal can be highly stressful for the professional facing the allegations. This is because these kinds of proceedings can disrupt, suspend or terminate a professional's license to practice their profession. Thus, it is necessary for one to handle such matters with care and fastidious attention to detail. At Caramanna, Friedberg LLP, they can be of help, as their legal team has expertise in representing…
Smart Dialysis System Market Growth Potential is Booming Now: Outset Medical, Me …
The latest study released on the Global Smart Dialysis System Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Smart Dialysis System market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the…
Investigation announced for Long-Term Investors in shares of Outset Medical, Inc …
An investigation was announced for long-term investors in shares of Outset Medical, Inc. (NASDAQ: OM) concerning potential breaches of fiduciary duties by certain directors and officers of Outset Medical, Inc.
Investors who are current long term investors in Outset Medical, Inc. (NASDAQ: OM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors in shares of Outset Medical, Inc. (NASDAQ: OM)
An investor, who purchased shares of Outset Medical, Inc. (NASDAQ: OM), filed a lawsuit alleged violations of Federal Securities Laws by Outset Medical, Inc.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 6, 2022. NASDAQ: OM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Jose, CA based Outset…
Investigation announced for Investors in shares of Outset Medical, Inc. (NASDAQ: …
An investigation was announced concerning potential securities laws violations by Outset Medical, Inc. in connection with certain statements.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series…
Hemodialysis Catheter Market – Utilisation Survey 2025 | Toray Medical Co., Lt …
Global Hemodialysis Catheter Market: Overview
Hemodialysis catheters are being extensively used to meet the growing demand of hemodialysis, apheresis, infusion, and monitoring of central venous pressure along with high-pressure contrast injection patients. It is predominantly used for maintaining effective blood flow rate, which is estimated at 400 ml/min for at least 3 hours. The growing number of patients suffering from end-stage renal disease (ESRD) have increased the demand for hemodialysis to…
